For years, Jazz Pharmaceuticals has dominated the market in treating narcolepsy with cataplexy. But increased competition is on the horizon. Classic treatment options Sodium oxybate — which in ...

The paper, titled “Understanding the Patient Experience With Twice-Nightly Sodium Oxybate Therapy for Narcolepsy: A Social Listening Experiment,” was published in Brain Sciences.

Sodium oxybate (Xyrem), a drug approved to treat people with narcolepsy, provided temporary relief for laryngeal dystonia patients whose symptoms were alcohol-responsive, a phase IIb, double-blind ...

Lumryz (sodium oxybate) is a prescription drug used to treat excessive daytime sleepiness or cataplexy from narcolepsy. Lumryz can cause side effects that range from mild to serious. Examples ...

The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

Sodium oxybate is a central nervous system agent that is FDA-approved to treat patients with narcolepsy and sleep disorders.

Recent Developments: The FDA approved Lumryz, an extended-release formulation of sodium oxybate, for treating cataplexy and EDS in narcolepsy patients aged 7 and older. Type: An oral orexin ...

Lumryz (sodium oxybate) is a brand-name oral liquid prescribed for narcolepsy in adults and certain children. As with other drugs, Lumryz can cause side effects, such as dizziness, nausea ...

The paper, titled “Understanding the Patient Experience With Twice-Nightly Sodium Oxybate Therapy for Narcolepsy: A Social Listening Experiment,” was published in Brain Sciences. “These findings ...